SimCorp A/S
1.3.2021 10:31:35 CET | Globenewswire | Press release
Company Announcement no. 05/2021
On February 10, 2021 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR.
In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 10, 2021 to July 31, 2021.
The following transactions have been executed under the program:
| Date | Number of shares | Average purchase price (DKK per share) | Amount (DKK) |
| Accumulated under the program as of last announcement: | 22,900 | 807.39 | 18,489,165 |
| February 22, 2021 | 3,000 | 790.23 | 2,370,690 |
| February 23, 2021 | 4,500 | 758.12 | 3,411,540 |
| February 24, 2021 | 4,000 | 766.53 | 3,066,120 |
| February 25, 2021 | 3,500 | 756.82 | 2,648,870 |
| February 26, 2021 | 4,000 | 748.71 | 2,994,840 |
| Accumulated under the program following above purchases: | 41,900 | 787.14 | 32,981,225 |
Following above purchases, SimCorp holds 743.587 treasury shares corresponding to 1.8% of the share capital.
Purchases for an amount of EUR 15.6m (approx. DKK 115.8m) remain to be executed under the program.
Enquiries regarding this announcement should be addressed to:
Anders Hjort, Head of Investor Relations, SimCorp A/S (+45 3544 8822)
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S27.3.2026 00:36:30 CET | Press release
Novo Nordisk A/S: Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
DBV Technologies S.A.26.3.2026 22:19:05 CET | Press release
DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document
DBV Technologies S.A.26.3.2026 22:06:11 CET | Press release
DBV Technologies Reports Full Year 2025 Financial Results and Business Update
Fortuna Mining Corp.26.3.2026 22:00:00 CET | Press release
Fortuna files Form 40-F, Annual Report
Galapagos NV26.3.2026 21:02:00 CET | Press release
Galapagos Announces Nomination of Gino Santini to its Board of Directors
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
